DRMTLGY / Needle-less Growth Factor Serum

Open the review comparison tray →

Peptides are named, and the brand explains their source

The ingredient list includes a humectant base, sodium hyaluronate, several oligopeptides and palmitoyl peptides, ceramides, phytosphingosine and cholesterol. DRMTLGY describes five bio-engineered growth-factor-inspired peptides and says the formula does not use human-derived ingredients. That is a useful source distinction, not proof that topical application reproduces the skin’s own signaling process.

The full list helps a buyer compare formulas and screen established sensitivities. It does not reveal the concentration or delivery of every peptide. The brand also cautions that online lists can change and directs buyers to packaging for the accurate formula, so a current bottle should take precedence over an old screenshot or a similarly named serum.

The reported trial has a real comparator and a small population

The page describes a randomized, double-blind, IRB-approved 12-week study with 20 participants divided between two topical treatments. It names the comparator and reports investigator-assessed differences at weeks eight and twelve. Those details provide a more concrete evidence question than an uncontrolled testimonial or a general peptide mechanism.

However, 20 participants is a limited population, and the complete report is needed to assess baseline balance, endpoints, withdrawals and statistical handling. IRB approval concerns research oversight; it does not itself prove superiority. We do not treat the product page’s summary as sufficient to independently validate every comparative claim.

Thirty percent greater improvement needs a defined scale

The brand reports a 30% greater overall visible improvement on the Global Aesthetic Improvement Scale and says it led in 73% of performance indicators. Those statements should not be converted into “30% fewer wrinkles” or “73% of users had better skin.” They describe the seller’s comparison and require the underlying methods to interpret correctly.

The advertised competitor price also serves a commercial comparison rather than a clinical endpoint. We have not independently refreshed that competitor’s price in this review, so we do not repeat it as a current universal cost. The practical price confirmed here is the selected DRMTLGY one-time offer, with temporary discounts kept separate.

The routine question is whether another serum is needed

The product is positioned before moisturizer and sunscreen, with directions allowing daily use. A reader already using another peptide or active serum should ask what distinct role this addition would fill. Combining two similarly named products is not automatically necessary to obtain the result reported for one tested formula.

We have not assessed finish, pilling or comfort under makeup, and the lack of a human-derived ingredient does not guarantee tolerance. Follow the product label and introduce unfamiliar skincare deliberately. A prescribed treatment or a recent procedure creates a more specific compatibility question than the brand’s broad normal, oily, dry and combination-skin categories can answer.

The 60-day policy has an authorization deadline

The direct-store return policy asks customers to contact support before 60 days from purchase for an authorization number, then postmark the return within two weeks of receiving it. It allows return of the unused portion, excludes shipping from the refund and can deduct the value of a missing promotional gift. Unauthorized returns carry a stated fee.

DRMTLGY’s strongest feature is a comparatively specific finished-product study claim at an identifiable $69 price. Its limitation is that the public summary does not replace a full independent review of that small trial. We leave performance unscored and would compare the exact formula, routine role and written return process before treating the comparative advertising as a settled verdict.